VAV1 and Alzheimer disease: A recent study reported that miRNA-330 overexpression in Alzheimer’s disease contributed to the reduction of amyloid β, oxidative stress, and mitochondrial dysfunction by targeting VAV1 through the MAPK pathway (Zhou et al., 2018).